Spectral AI Inc (MDAI) concluded trading on Wednesday at a closing price of $2.06, with 5.89 million shares of worth about $12.13 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.71% during that period and on January 22, 2025 the price saw a loss of about -1.44%. Currently the company’s common shares owned by public are about 18.51M shares, out of which, 11.12M shares are available for trading.
Stock saw a price change of 5.10% in past 5 days and over the past one month there was a price change of 15.73%. Year-to-date (YTD), MDAI shares are showing a performance of -27.21% which increased to 0.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.82 but also hit the highest price of $3.72 during that period. The average intraday trading volume for Spectral AI Inc shares is 2.46 million. The stock is currently trading -11.19% below its 20-day simple moving average (SMA20), while that difference is up 6.82% for SMA50 and it goes to 23.89% higher than SMA200.
Spectral AI Inc (NASDAQ: MDAI) currently have 18.51M outstanding shares and institutions hold larger chunk of about 10.29% of that.
The stock has a current market capitalization of $43.78M and its 3Y-monthly beta is at 0.41. It has posted earnings per share of -$0.66 in the same period. It has Quick Ratio of 0.69. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MDAI, volatility over the week remained 12.51% while standing at 13.82% over the month.
Analysts are in expectations that Spectral AI Inc (MDAI) stock would likely to be making an EPS of -0.14 in the current quarter, while forecast for next quarter EPS is -0.23 and it is -0.7 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.18 which is -0.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.22 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 66.44% while it is estimated to decrease by -10.74% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on January 23, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it.
